Press Releases

Primerdesign Appoints Scientific Laboratory Supplies as Academic UK Distributor

• Offers UK academic research institutions improved access to Primerdesign’s real-time PCR assays and reagents with reliable, fast and local support • SLS to showcase Primerdesign portfolio at Lab Innovations in Birmingham, UK (29–30 October)

EazeBio and UC Santa Cruz Announce Strategic Partnership to Advance Instrument-Free Diagnostic Platform

EazeBio has announced a strategic partnership with the University of California, Santa Cruz to advance and commercialize a groundbreaking instrument-free diagnostic platform.

Spaarne Gasthuis to Advance its Commitment to Patient Care with Proscia’s Software

Spaarne Gasthuis, a top clinical teaching hospital serving part of the Greater Amsterdam region, is fully digitizing its pathology practice with Concentriq® AP-Dx* from Proscia®. With this software platform, the hospital will empower its pathologists to play an even more significant role in guiding personalized treatment decisions for hundreds of thousands of patients each year.

Molsid Announces Successful Completion of Clinical Study for Its First Diagnostic Kit, ResiScreen® Staph, improving antimicrobial resistance detection

Molsid, a French biotech company, announces the successful completion of the clinical performance study for ResiScreen® Staph, an innovantive solution for faster detection of staphylococcal beta-lactamase. Powered by Molsid's patented SmartID® fluorescent biotracer technology, ResiScreen® Staph reaffirms the company's mission to deliver next-generation diagnostic technologies to support clinical laboratories in the contention of antimicrobial resistance.

DNAnexus Honored with Frost & Sullivan’s 2025 Technology Innovation Leadership Award

Recognized for Global Precision Health Informatics Industry Excellence in Best Practices

Syngene International invests in dedicated peptide laboratory and advanced automation

KLAS Emerging Solutions Report: Ambience Healthcare Ranked #1 in Improving Clinician Experience, Top 3 in Both Improving Patient Experience and Improving Outcomes

Creative Diagnostics Launches Validated Inorganic Pyrophosphatase ELISA Kits for mRNA Vaccine Production Quality Control

Creative Diagnostics introduces a comprehensive suite of validated Inorganic Pyrophosphatase ELISA Kits for the research community.

STEMart Launches Advanced Bacterial Reverse Mutation Test (Ames) Service to Accelerate Medical Device Safety Assessment

STEMart announces the launch of its Bacterial Reverse Mutation Test (Ames) service.

eClinical Solutions and ZS Announce Strategic Partnership to Deliver a New Industry Standard for RBQM

Collaboration unites elluminate platform technology and ZS RBQM expertise to offer a fully integrated, data-driven approach to risk and quality management

Proscia to Broaden Pathology AI Capabilities with Biomarker Detection for Skin Tissue

Proscia®, a pathology AI company, will add AI biomarker detection for skin tissue to its Concentriq® software platform, empowering pathologists to drive efficiency and precision. Powered by Primaa, Cleo Skin* will strengthen Concentriq's lead in offering the industry’s broadest portfolio of AI solutions on a single platform.

Baylor Genetics Presents New Data on Clinical and Diagnostic Utility of RNA Sequencing for Rare Disease at the American Society of Human Genetics 2025 Annual Meeting

Baylor Genetics Presents New Data on Clinical and Diagnostic Utility of RNA Sequencing for Rare Disease at the American Society of Human Genetics 2025 Annual Meeting

Scanogen Receives FDA Breakthrough Device Designation for Rapid Bloodstream Infection Assay

Scanogen Inc., a Maryland-based molecular diagnostics company, announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to its rapid assay for bloodstream infection pathogen identification. The company’s SMART platform delivers species-level results in just two hours—compared to several days with current blood culture methods—enabling earlier, targeted antimicrobial therapy that can improve sepsis outcomes and reduce healthcare costs. Supported by multiple NIH research grants, Scanogen is now raising a Series A financing round to fund pivotal clinical studies and bring this transformative technology to market.

Gifthealth is First to Serve 6m Patients Via Direct-to-Patient Platform

Gifthealth, the patient access solution that unifies the prescription journey from provider to patient, today announced it has now served more than six million patients through its direct-to-patient (DTP) platform.

CluePoints’ AI Breakthroughs Earn Dual Recognition at SCDM and SCRIP Awards

CluePoints, provider of leading statistical and AI-driven software solutions, has achieved dual recognition, winning the Clinical Data Science Implementation Excellence Award at the 2025 SCDM Annual Conference and has been named a finalist in the ‘Best Contract Research Organization– Specialist Providers’ category at the 2025 SCRIP Awards.

Association for Molecular Pathology Develops Standardized Biomarker Report Template for Providers

AMP announced the publication of a new simplified, consensus-driven NGS molecular biomarker report designed to support oncologists and other healthcare providers. This report provides clear, practical recommendations to help laboratories present complex molecular profiling data in a format that is both clinically useful and consistent with current guidelines.

Phastar Scoops Multiple Finalist Positions in 2025 SCRIP Awards

Phastar, a global specialist biometrics & data science Contract Research Organization (CRO), has been named as finalists in two categories at the prestigious 2025 SCRIP Awards.

Baylor Genetics Earns 2025 Great Place To Work Certification™

Baylor Genetics, a clinical diagnostic laboratory at the forefront of genetic testing, is proud to be Certified™ by Great Place To Work®! The prestigious award is based entirely on what current employees say about their experience working at Baylor Genetics. This recognition is based entirely on feedback from current employees about their workplace experience. In 2025, Baylor Genetics employees rated the company 17 points higher than the average U.S. workplace.

Clearwater Receives Strategic Growth Investment from Sunstone Partners

Ambience Healthcare Becomes First Ambient AI Platform to Launch Inpatient CDI at the Point of Care, Built on OpenAI